RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2007; 132(25/26): 1368-1370
DOI: 10.1055/s-2007-982036
DOI: 10.1055/s-2007-982036
Klinischer Fortschritt | Commentary
© Georg Thieme Verlag KG Stuttgart · New York
Hypertensiologie 2007
Hypertensiology 2007Weitere Informationen
Publikationsverlauf
eingereicht: 7.5.2007
akzeptiert: 15.5.2007
Publikationsdatum:
15. Juni 2007 (online)

Was ist neu?
-
Behandlungsqualität der Hypertonie in Deutschland deutlich verbessert
-
Schlaganfälle in den letzten Jahren rückläufig
-
Weniger Kochsalz, mehr Schokolade senkt den Blutdruck und die Mortalität
-
Neues von der J-Kurve
-
Erster Renin-Inhibitor zugelassen
Literatur
- 1
Adrogué H J, Madias N E.
Sodium and Potassium in the Pathogenesis of Hypertension.
N Eng J Med.
2007;
356
196-178
MissingFormLabel
- 2
Appel L J, Moore T J. et al. for the DASH Collaborative Research Group .
A clinical trial of the effects of dietary patterns on blood pressure.
N Engl J Med.
1997;
336
1117-1124
MissingFormLabel
- 3
Buijsse B, Feskens E, Kok F, Kromhout D.
Cocoa Intake, Blood Pressure, and Cardiovascular Mortality. The Zutphen Elderly Study.
Arch Intern Med.
2006;
166
411-417
MissingFormLabel
- 4
Cook N R, Cutler J A, Obarzanek E. et al .
Long term effects of dietary sodium reduction on cardiovascular disease outcomes:
observational follow-up of the trials of hypertension prevention (TOHP).
BMJ.
2007;
Apr 28; 334 (7599)
885
MissingFormLabel
- 5
Gradman A H. et al .
Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive
efficacy and placebo-like tolerability in hypertensive patients.
Circulation.
2005;
111
1012-1018
MissingFormLabel
- 6
Julius S t. et al .
Feasibility of Treating Prehypertension with an Angiotensin-Receptor Blocker.
N Engl J Med.
2006;
354
1685-1697
MissingFormLabel
- 7 Lemmer B, Middeke M, Schaaf B, Eckes L. Prescribing practices and morning blood pressure control: results of a large scale,
primary-care study conducted in germany. 21st Scientific Meeting of the Int Soc Hypertens, Proceedings, abstract p.94 2006
MissingFormLabel
- 8
Löwel H, Meisinger C. et al .
Epidemiologie der arteriellen Hypertonie in Deutschland.
Dtsch Med Wochenschr.
2006;
131
2586-2591
MissingFormLabel
- 9
MacGregor G A, Sagnella G A. et al .
Double-blind study of three sodium intakes and long-term effects of sodium restriction
in essential hypertension.
Lancet.
1989;
11
1244-1247
MissingFormLabel
- 10
Meisinger C, Heier M, Völzke H. et al .
Regional disparities of hypertension prevalence and management within Germany.
Hypertension.
2006;
24
293-299
MissingFormLabel
- 11
Messerli F H, Mancia G, Conti R. et al .
Dogma Disputed: Can Aggressively Lowering Blood Pressure in Hypertensive Patients
with Coronary Artery Disease Be Dangerous?.
Ann Intern Med.
2006;
144
884-893
MissingFormLabel
- 12
Middeke M.
Die U-förmige Beziehung zwischen nächtlichem Blutdruck und Organschäden.
Dtsch Med Wochenschr.
2005;
130
2640-2642
MissingFormLabel
- 13
Schroeter H, Heiss Ch. et al .
(-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function
in humans.
Proc Natl Acad Sci U S A.
2006;
103
1024-1029
MissingFormLabel
- 14 Silber S. Ergebnisse einer Snapshot Umfrage des BNK. 30. Wiss. Kongress der Deutschen Hochdruckliga, München 2006
MissingFormLabel
- 15 Statistisches Bundesamt Deutschland - .Gesundheitswesen. www.gbe-bund.de
MissingFormLabel
- 16
van Tassell B, Munger M.
Aliskiren for Renin Inhibition: A New Class of Antihypertensives.
The Annals of Pharmacotherapy.
2007;
41
456-464
MissingFormLabel
- 17
Wang Y, Alexander G, Stafford R.
Outpatient Hypertension Treatment, Treatment Intensification, and Control in Western
Europe and the Unites States.
Arch Intern Med.
2007;
167
141-147
MissingFormLabel
- 18
Wolf-Maier K, Cooper R. et al .
Hypertension Prevalence and Blood Pressure Levels in 6 European Countries, Canada,
and the United States.
JAMA.
2003;
289
2363-2369
MissingFormLabel
- 19
Wood J M, Maibaum J, Rahuel J.
Structure based design of alsikiren, a novel orally effective renin inhibitor.
Biochem Biophys Res Commun.
2003;
308
698-705
MissingFormLabel
Prof. Dr. med. Martin Middeke
Blutdruckinstitut München
Osterwaldstraße 69
80805 München
eMail: info@blutdruckinstitut.de
URL: http://www.blutdruckinstitut.de